FDA Risk Assessment Favorable to Food from Clones

The New Standard has published an article outlining how the FDA has "cherry-picked" data in formulating a favorable risk assessment for food products from cloned animals. Read the article here. Read the Center for Food Safety report on the issue here. Read the FDA draft risk assessment here.

read in full

Breaking down FDA's New Conflict-of-Interest Proposal

In today's New York Times, there appears a story by reporter Gardiner Harris about FDA's new guidance intending to reduce conflicts of interest on agency advisory boards. (Note: The story refers to the proposal as "rules" but it is actually "draft guidance" which, unlike rules/regulations, does not carry the force of law.) The guidance is a response to an increasing problem at FDA: Scientists determining the public safety of drugs and medical devices often have financial ties to the products or industry on which they are commenting. There are pros and cons to the draft guidance. The good:

read in full

Economic Research Suffers in Bush Proposed Budget

A report by EPA's Science Advisory Board (SAB) points out President Bush's budget request proposes a cut in funding devoted to economic research at EPA. In this case, the research is needed to develop cost-benefit analyses which in turn are needed to promulgate regulations. The proposed budget calls for a 58 percent cut in funding for what the report calls "Economics and Decision Sciences." EPA would consolidate offices and personnel to accomplish the cut. From the report: SAB is concerned that consolidation might actually decrease the amount of economics research at EPA and also impede the development of a high quality research portfolio in behavioral social and decision sciences. The White House consistently claims that economic factors should be paramount in the regulatory process, but this proposed cut belies their rhetoric. President Bush is not concerned with how regulations might improve the economic standing of the American people. He is only concerned with delaying regulations so that corporate interests will benefit.

read in full

Consumer Protection Agency Reaches out through Email Campaign

The Consumer Product Safety Commission, an independent federal agency, has launched an excellent campaign to inform consumers of product recalls. The "Drive to 1 million" aims to subscribe one million Americans to CPSC's email notifications. The emails alert subscribers to recalls of dangerous or potentially dangerous products. Sign up for free at www.cpsc.gov.

read in full

House Presses Bush Officials on Political Interference in Climate Science

As Reg•Watch blogged yesterday, a House committee held a hearing to investigate the Bush administration's manipulation of government climate science. The hearing was the second by the Oversight and Government Reform Committee to examine political interference in climate science. Chairman Henry Waxman (D-CA) called the first hearing after the White House Council on Environmental Quality's refused to turn over documents the committee had requested. In his opening remarks, Waxman said CEQ has turned over eight boxes but has not yet fulfilled the months old request. Still, the evidence the committee has seen "suggests there may have been a concerted effort directed by the White House to mislead the public about the dangers of global climate change." The testimony of Philip Cooney was nothing to write home about. Cooney was CEQ chief of staff (in between stints at the American Petroleum Institute and Exxon-Mobil) until 2005. He resigned after it was discovered he had altered climate science documents to plant seeds of doubt. Not surprisingly, Cooney claimed his actions were completely justified and cited a National Academies of Science report as his basis. The committee quickly shot holes through his defense. Waxman pressed Cooney on a verbatim quote from the NAS report he had completely removed. The sentence indicated the breadth and severity of climate change. Read more from The New York Times

read in full

Political Interference in Climate Science

Today, the House Oversight and Government Reform Committee will hold a hearing investigating the integrity of climate science in the Bush administration. The hearing will feature testimony from James Connaughton, the chairman of the White House Council on Environmental Quality, and Phillip Cooney, the former administration official who blatantly altered scientific findings to match the White House's distorted view of global climate change. The hearing is the second in a series, the first of which uncovered numerous incidences of political interference in the work of government climate scientists. Reg•Watch will post a recap in the near future. In the meantime, you can watch the hearing live here.

read in full

OMB Watch Releases Report on Bush Changes to Regulatory Process

Today, OMB Watch released a full report titled A Failure to Govern: Bush's Attack on the Regulatory Process (download it here). This report outlines President Bush's recent amendments to Executive Order 12866 — Regulatory Planning and Review. The report details the potential impacts the amendments will have on federal agencies and the American public, as well as what the changes mean to democracy at large. A Failure to Govern: Bush's Attack on the Regulatory Process

read in full

Please Protect the Food Supply ... You Know - If You Feel Like It

On Monday, the U.S. Food and Drug Administration (FDA) issued to the produce industry guidance on reducing the risk of contamination in fresh-cut fruits and vegetables. The "guidance" (regulatory lingo for "suggestion") urges the industry to develop food safety plans. The guidance is completely voluntary. FDA's nonchalance is odd considering recent events. Highly publicized food-borne illness outbreaks — such as the E. Coli tainted spinach of 2006 and the current case of salmonella in peanut butter — have raised concern over the safety of our nation's food supply. One would think America's leading food monitor would begin to do its job with more, not less vigor. See this Associated Press article for more.

read in full

FDA Commissioner Opposes Commonsense Tobacco Bill

FDA commissioner Dr. Andrew von Eschenbach is opposed to bipartisan legislation that would allow FDA to regulate tobacco products. Sensible bills in both the House and the Senate would dramatically improve public health as it relates to tobacco products. The bill would do so by placing the tobacco industry — which currently goes unregulated — under the purview of FDA. In a Mar. 6 interview with the Associated Press, von Eschenbach manipulates the facts in his opposition to the bill. His specious arguments are a poorly veiled attempt to side with the tobacco industry. He also claimed tobacco products are too complex for the FDA to handle. How can an FDA commissioner hold such little regard for his own agency? One of the bills sponsors, Rep. Henry Waxman (D-CA), wrote a letter to von Eschenbach asking him to correct his various misstatements. Your statements suggest a serious misunderstanding of the bill and appear to ignore overwhelming evidence that such regulation is necessary to address the continuing epidemic of tobacco-related death and disease. Waxman then discredits von Eschenbach's argument point by point. Waxman's letter is a pleasure to read (as his Bush administration proddings usually are). Check this one out here.

read in full

High-profile Opposition to Bush Regulatory Changes

The Environmental Forum, a bimonthly publication of the Environmental Law Institute, has published ">six opinions pieces on President Bush's changes to the regulatory process. The magazine features three opinions in favor of the changes and three opposed, including a piece by OMB Watch Executive Director Gary Bass. Of particular concern is the opinion of John G. Knepper, Deputy General Counsel of OMB. One new amendment requires agency Regulatory Policy Officers (RPO) be presidential appointees. Knepper argues this will make those officials more accountable to Congress and the public. But the Executive Order does not require the Senate to approve the RPO. Knepper, presumably involved in the drafting of the changes, should be more forthright in his argument. In opposition, Rep. Henry Waxman (D-CA) reinforced the common conclusion that the White House — in the face of an opposition Congress — is attempting in its last two years to leave an anti-regulatory legacy. Waxman articulates the underhanded Bush tactic with a great simile: "Like a retreating army that mines the road behind it, the Bush administration is erecting new barriers to prevent commonsense safeguards from advancing in the next administration."

read in full

Pages

Subscribe to The Fine Print: blog posts from Center for Effective Government